1
|
Lema C, Cheng KW, Anderson DM, Miller CC, Karp DD, McPherson DD, Kolar SSN. Simultaneous submission of seven CTSA proposals: UM1, K12, R25, T32-predoctoral, T32-postdoctoral, and RC2: strategies, evaluation, and lessons learned. J Clin Transl Sci 2024; 8:e33. [PMID: 38384924 PMCID: PMC10880001 DOI: 10.1017/cts.2024.14] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2023] [Revised: 01/09/2024] [Accepted: 01/17/2024] [Indexed: 02/23/2024] Open
Abstract
Translation is the process of turning observations in the research laboratory, clinic, and community into interventions that improve people's health. The Clinical and Translational Science Awards (CTSA) program is a National Center for Advancing Translational Sciences (NCATS) initiative to advance translational science and research. Currently, 64 "CTSA hubs" exist across the nation. Since 2006, the Houston-based Center for Clinical Translational Sciences (CCTS) has assembled a well-integrated, high-impact hub in Texas that includes six partner institutions within the state, encompassing ∼23,000 sq. miles and over 16 million residents. To achieve the NCATS goal of "more treatments for all people more quickly," the CCTS promotes diversity and inclusion by integrating underrepresented populations into clinical studies, workforce training, and career development. In May 2023, we submitted the UM1 application and six "companion" proposals: K12, R25, T32-Predoctoral, T32-Postdoctoral, and RC2 (two applications). In October 2023, we received priority scores for the UM1 (22), K12 (25), T32-Predoctoral (20), and T32-Postdoctoral (23), which historically fall within the NCATS funding range. This report describes the grant preparation and submission approach, coupled with data from an internal survey designed to assimilate feedback from principal investigators, writers, reviewers, and administrative specialists. Herein, we share the challenges faced, the approaches developed, and the lessons learned.
Collapse
Affiliation(s)
- Carolina Lema
- Center for Clinical and Translational Sciences (CCTS), The
University of Texas Health Science Center at Houston, Houston,
TX, USA
| | - Kwai Wa Cheng
- Center for Clinical and Translational Sciences (CCTS), The
University of Texas Health Science Center at Houston, Houston,
TX, USA
| | - Delanderia M. Anderson
- Center for Clinical and Translational Sciences (CCTS), The
University of Texas Health Science Center at Houston, Houston,
TX, USA
| | - Charles C. Miller
- Center for Clinical and Translational Sciences (CCTS), The
University of Texas Health Science Center at Houston, Houston,
TX, USA
- Department of Cardiothoracic and Vascular Surgery, The
University of Texas Health Science Center at Houston, McGovern Medical
School, Memorial Hermann Heart & Vascular Institute, Houston,
TX, USA
| | - Daniel D. Karp
- Center for Clinical and Translational Sciences (CCTS), The
University of Texas Health Science Center at Houston, Houston,
TX, USA
- Department of Investigational Cancer Therapeutics, The
University of Texas MD Anderson Cancer Center, Houston,
TX, USA
| | - David D. McPherson
- Center for Clinical and Translational Sciences (CCTS), The
University of Texas Health Science Center at Houston, Houston,
TX, USA
- Department of Internal Medicine, Division of Cardiology, The
University of Texas Health Science Center at Houston, McGovern Medical
School, Houston, TX, USA
| | - Satya Sree N. Kolar
- Center for Clinical and Translational Sciences (CCTS), The
University of Texas Health Science Center at Houston, Houston,
TX, USA
| |
Collapse
|